Fig. 1: Responses to induction therapy in MM.

For each study, the PFS and OS columns state whether achievement of the response deemed to be ‘sufficient’ was associated with any benefit by any statistical method; question marks mean that the specific endpoint was not investigated. ASCT autologous stem cell transplantation, CR complete response, MM multiple myeloma, MR minimal response, MRD-neg measurable residual disease negativity, OS overall survival, PCs plasma cells on bone marrow biopsy, PD progressive disease, PFS progression-free survival, SD stable disease, VGPR very good partial response.